A Selective Inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a Treatment for Ischemia-Reperfusion Injury is a research paper published in Pharmaceuticals (2022). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
American Heart Association
Grant: 19POST34380299
São Paulo Research Foundation
Grant: 2018/18627-3
National Institute of Health
Grant: R01-HL052141
NHLBI NIH HHS
Grant: R01 HL052141
NHLBI NIH HHS
Grant: T32 HL094274
FWCI
1.08
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals